Zhang, J., Yao, T., Lin, Z., & Gao, Y. (2017). Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Zhang, Jun, Tingting Yao, Zhongqiu Lin, y Yali Gao. Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer. Nature Portfolio, 2017.
Cita MLA (8a ed.)Zhang, Jun, et al. Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer. Nature Portfolio, 2017.
Precaución: Estas citas no son 100% exactas.